Revium Rx (RVRC) Accounts Payables (2024 - 2026)
Revium Rx's (RVRC) quarterly Accounts Payables came in at $620000.0 in Q2 2026, up 280.37% quarter-over-quarter from $163000.0 in Q4 2025.
Analysis
Revium Rx (RVRC) Accounts Payables (2024 - 2026) Analysis & Trends
Revium Rx has disclosed Accounts Payables across 3 years of filings, most recently posting $620000.0 for Q2 2026.
- In Q2 2026, Accounts Payables changed N/A year-over-year to $620000.0; the TTM figure through Jun 2026 stood at $620000.0 (changed N/A YoY), while the FY2025 annual figure was $163000.0, up 14.79% from the prior year.
- Accounts Payables came in at $620000.0 for Q2 2026 at Revium Rx, up from $163000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $620000.0 in Q2 2026 to a low of $142000.0 in Q4 2024.
- Average Accounts Payables over 3 years is $308333.3, with a median of $163000.0 recorded in 2025.
- The largest YoY upside for Accounts Payables was 14.79% in 2025 against a maximum downside of 14.79% in 2025.
- Over 3 years, Accounts Payables stood at $142000.0 in 2024, then advanced by 14.79% to $163000.0 in 2025, then surged by 280.37% to $620000.0 in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $620000.0 in Q2 2026, $163000.0 in Q4 2025, and $142000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Revium Rx | 86.84 Mn | 85.34 Mn | - | 620,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 620,000.00 |
| Dec 31, 2025 | 163,000.00 |
| Dec 31, 2024 | 142,000.00 |